Pharmacy and Pharmacology Communications

Guest Editorial
pp. 229-229(1)

Medical Uses and Toxicological Profile of Cannabis
pp. 231-234(4)
Author: Mascolo N.

Regulation of Endocannabinoid Levels under Physiological and Pathological Conditions. A Mini-review
pp. 235-241(7)
Author: Di Marzo V.

Rat Cognitive Functions During and After Treatment with the Cannabinoid Agonist, HU 210
pp. 243-246(4)
Authors: Ottani A.; Giuliani D.; Ferrari F.

Potassium Channels: K_ATP and BK_Ca in Vascular Smooth Muscle
pp. 247-253(7)
Authors: Calderone V.; Martinotti E.

In-vivo Modulation of Gastrointestinal Motility by Cannabinoid Drugs
pp. 255-258(4)
Authors: Izzo A.A.; Addeo D.; Amato M.; Borrelli F.; Capasso R.; Di Carlo G.; Nocerino E.; Mascolo N.; Pinto L.; Capasso F.

Endocannabinoids and Peripheral Pain
pp. 259-262(4)
Authors: La Rana G.; Lobello R.M.; Piomelli D.; Calignano A.

Effects of the Cannabinoid Receptor Agonist, HU 210, on Body Weight and Feeding Behaviour of Rats
pp. 263-266(4)
Authors: Giuliani D.; Ottani A.; Ferrari F.

Interaction between Opioids and Cannabinoids in the Immune System: Functional Evidence in the Rat
pp. 267-271(5)
Authors: Massi P.; Vaccani A.; Parolaro D.

Cannabinoid CB₁ Receptors Are Involved in the Regulation of Rat Gastric Acid Secretion
pp. 273-275(3)
Authors: Adami M.; Bertini S.; Frati P.; Soldani G.; Coruzzi G.

Cannabinoids Regulate -Opioid Receptors in NG108-15 Hybrid Cells
pp. 277-280(4)
Authors: Di Toro R.; Spampinato S.

Role of Cannabinoid CB₁ Receptor in Morphine Rewarding Effects in Mice
pp. 281-285(5)
Authors: Fattore L.; Cossu G.; Mascia M.S.; Obinu M.C.; Ledent C.; Parmentier M.; Imperato A.; Böhme G.A.; Fratta W.

Relationship between Cannabinoid CB₁ and Dopamine D₂ Receptors in Intestinal Motility in Mice
pp. 287-291(5)
Authors: Carai M.A.M.; Agabio R.; Lobina C.; Pani M.; Reali R.; Vacca G.; Colombo G.; Gessa G.L.